IL112849A - Isoxazoline compounds as 5-lipoxygenase inhibitors - Google Patents
Isoxazoline compounds as 5-lipoxygenase inhibitorsInfo
- Publication number
- IL112849A IL112849A IL11284995A IL11284995A IL112849A IL 112849 A IL112849 A IL 112849A IL 11284995 A IL11284995 A IL 11284995A IL 11284995 A IL11284995 A IL 11284995A IL 112849 A IL112849 A IL 112849A
- Authority
- IL
- Israel
- Prior art keywords
- lipoxygenase inhibitors
- isoxazoline compounds
- isoxazoline
- compounds
- lipoxygenase
- Prior art date
Links
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 title 1
- 150000002547 isoxazolines Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20876894A | 1994-03-09 | 1994-03-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL112849A0 IL112849A0 (en) | 1995-06-29 |
| IL112849A true IL112849A (en) | 1999-04-11 |
Family
ID=22775981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11284995A IL112849A (en) | 1994-03-09 | 1995-03-02 | Isoxazoline compounds as 5-lipoxygenase inhibitors |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5696141A (xx) |
| EP (1) | EP0749307A1 (xx) |
| JP (1) | JPH09505081A (xx) |
| AU (1) | AU1326795A (xx) |
| CA (1) | CA2184914C (xx) |
| FI (1) | FI963509A (xx) |
| IL (1) | IL112849A (xx) |
| MX (1) | MX9603943A (xx) |
| MY (1) | MY112586A (xx) |
| WO (1) | WO1995024192A1 (xx) |
| ZA (1) | ZA951911B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3563842A1 (en) | 2009-04-29 | 2019-11-06 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62103070A (ja) * | 1985-10-29 | 1987-05-13 | Mitsui Toatsu Chem Inc | イソオキサゾリン誘導体および植物生長調節剤 |
| HU215433B (hu) * | 1986-04-29 | 2000-05-28 | Pfizer Inc. | Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására |
| IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
| US4731382A (en) * | 1986-12-29 | 1988-03-15 | Bristol-Myers Company | Lipoxygenase inhibitory phenylalkanohydroxamic acids |
| FR2639636B1 (fr) * | 1988-11-30 | 1994-03-04 | Novapharme | Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant |
| IL92915A0 (en) * | 1989-01-05 | 1990-09-17 | Ciba Geigy Ag | Certain pyrrolylphenyl-substituted hydroxamic acid derivatives |
| CA2017383A1 (en) * | 1989-06-08 | 1990-12-08 | Raymond R. Martodam | Use of vanilloids for the treatment of respiratory diseases or disorders |
| WO1991007177A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| DE3939010A1 (de) * | 1989-11-25 | 1991-05-29 | Hoechst Ag | Isoxazoline, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschuetzende mittel |
| JP2787602B2 (ja) * | 1990-01-24 | 1998-08-20 | 大鵬薬品工業株式会社 | イソキサゾリン誘導体 |
| US5234937A (en) * | 1990-03-27 | 1993-08-10 | Warner-Lambert Company | 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents |
| GB9007762D0 (en) * | 1990-04-05 | 1990-06-06 | Beecham Group Plc | Novel compounds |
| WO1992007567A1 (en) * | 1990-11-06 | 1992-05-14 | Smithkline Beecham Corporation | Imidazolidinone compounds |
| PT100441A (pt) * | 1991-05-02 | 1993-09-30 | Smithkline Beecham Corp | Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso |
| US5140047A (en) * | 1991-05-03 | 1992-08-18 | Smithkline Beecham Corporation | Lipoxygenase inhibitors |
| GB9215921D0 (en) * | 1992-07-27 | 1992-09-09 | Wellcome Found | Anti-inflammatory compounds |
| US5288397A (en) * | 1992-09-18 | 1994-02-22 | Mobil Oil Corporation | Baffled FCC regeneration process and apparatus |
| WO1994018158A1 (en) * | 1993-02-15 | 1994-08-18 | Pfizer Inc. | Spiroalkylhydroxyureas for use as lipoxygenase inhibitors |
-
1995
- 1995-01-19 JP JP7523327A patent/JPH09505081A/ja active Pending
- 1995-01-19 US US08/700,432 patent/US5696141A/en not_active Expired - Fee Related
- 1995-01-19 EP EP95904684A patent/EP0749307A1/en not_active Withdrawn
- 1995-01-19 AU AU13267/95A patent/AU1326795A/en not_active Abandoned
- 1995-01-19 MX MX9603943A patent/MX9603943A/es not_active IP Right Cessation
- 1995-01-19 WO PCT/IB1995/000041 patent/WO1995024192A1/en not_active Application Discontinuation
- 1995-01-19 CA CA002184914A patent/CA2184914C/en not_active Expired - Fee Related
- 1995-03-02 IL IL11284995A patent/IL112849A/xx not_active IP Right Cessation
- 1995-03-07 MY MYPI95000574A patent/MY112586A/en unknown
- 1995-03-08 ZA ZA951911A patent/ZA951911B/xx unknown
-
1996
- 1996-09-06 FI FI963509A patent/FI963509A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2184914A1 (en) | 1995-09-14 |
| ZA951911B (en) | 1996-09-09 |
| IL112849A0 (en) | 1995-06-29 |
| JPH09505081A (ja) | 1997-05-20 |
| FI963509A0 (fi) | 1996-09-06 |
| AU1326795A (en) | 1995-09-25 |
| MY112586A (en) | 2001-07-31 |
| FI963509A (fi) | 1996-09-06 |
| US5696141A (en) | 1997-12-09 |
| CA2184914C (en) | 2000-09-19 |
| WO1995024192A1 (en) | 1995-09-14 |
| EP0749307A1 (en) | 1996-12-27 |
| MX9603943A (es) | 1997-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9407812D0 (en) | Compounds | |
| GB9414193D0 (en) | Compounds | |
| GB9414208D0 (en) | Compounds | |
| GB9404706D0 (en) | Compounds | |
| GB9407435D0 (en) | Compounds | |
| GB9403199D0 (en) | Compounds | |
| GB9402197D0 (en) | Compounds | |
| GB9400413D0 (en) | Compounds | |
| GB9417938D0 (en) | Compounds | |
| IL112849A (en) | Isoxazoline compounds as 5-lipoxygenase inhibitors | |
| GB9402041D0 (en) | Compounds | |
| ZA945085B (en) | 5-Lipoxygenase inhibitors | |
| GB9402603D0 (en) | Compounds | |
| GB9420111D0 (en) | Heterocycle compounds | |
| GB9426027D0 (en) | 0rganic compounds | |
| GB9426032D0 (en) | 0rganic compounds | |
| GB9406182D0 (en) | Compounds | |
| GB9420093D0 (en) | Compounds | |
| GB9406394D0 (en) | Compounds | |
| GB9420057D0 (en) | Compounds | |
| GB9406399D0 (en) | Compounds | |
| GB9420045D0 (en) | Compounds | |
| GB9420060D0 (en) | Compounds | |
| GB9420081D0 (en) | Compounds | |
| GB9407511D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |